1. HBW Insight
  2. >>Health
  3. >>Business
  4. >>Deals

Cooper Consumer Health Expands With France's Tradiphar

 
• By Tom Gallen

Cooper Consumer Health - formerly Alpha HealthGroup - said it had gained a portfolio of "high profile brands" and strengthened its position in Europe's OTC market with the acquisition of France's Tradiphar.

Euro currency
• Source: Shutterstock

Cooper Consumer Health – formerly known as Alpha HealthGroup – is poised to strengthen its brand portfolio in Europe with the acquisition of France’s Laboratoire Tradiphar for an undisclosed sum.

Under the terms of the deal, private equity-backed Cooper has entered into an exclusive negotiation agreement to purchase 100% of...

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Deals

Prestige Consumer Starting Clear Eyes Production With No Contract Partner ‘Out There To Tap Into’

 
• By Malcolm Spicer

PCH lowers full-year guidance even after reaching $100m deal to acquire Canadian sterile ophthalmic manufacturer for its Clears Eyes line troubled by supply slumps for several years. Its $47.5m reported net sales for April-June period were down 6% from a year ago.

Navamedic To Market OTC Naloxone In Norway Following Switch

 
• By Tom Gallen

Navamedic adds Ventizolve to its portfolio shortly after Norway switched the opioid overdose reversal drug from Rx to OTC.

Reckitt Strikes Deal To Sell Essential Home Unit To Focus On CHC, Hygiene

 
• By Tom Gallen

Advent International is poised to take control of Reckitt's Essential Home business, but the UK-based firm will retain a 30% stake.

Perrigo Implements Streamlining Plan With Sale Of Dermacosmetics

 
• By Tom Gallen

Perrigo stands to gain up to €327m with sale of brands such as ACO and Emolium to KKR.

More from Business

Moberg Has US Ambitions For Novel Nail Fungus Treatment

 
• By Tom Gallen

Sweden's Moberg wants to introduce its onychomycosis treatment to the US but expects it will need to complete an additional study to win FDA approval.

People On The Move: Appointments At Enzymatica, Haleon, Futura

 
• By Tom Gallen

A round up of the latest moves in Europe's consumer health market: Enzymatica appoints CEO; Haleon hires DACH marketing chief; Futura confirms interim CEO.

Primatene Mist Sales Flat As Amphastar Plans Production Expansion To Support Pipeline

 
• By Malcolm Spicer

Amphastar plans three- to five-year expansion to quadruple production capacity for its US manufacturing operations at its Rancho Cucamonga, CA, headquarters. Primatene Mist Q2 sales reached $22.88m from $22.86m a year ago.